These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22186988)

  • 1. Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study.
    Finger PT; Chin KJ
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):85-9. PubMed ID: 22186988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctival bevacizumab injection for ocular surface squamous neoplasia.
    Faramarzi A; Feizi S
    Cornea; 2013 Jul; 32(7):998-1001. PubMed ID: 23538634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of subconjunctival ranibizumab in patients with primary pterygium undergoing pterygium surgery.
    Galor A; Yoo SH; Piccoli FV; Schmitt AJ; Chang V; Perez VL
    Am J Ophthalmol; 2010 Jun; 149(6):926-931.e2. PubMed ID: 20417925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension.
    Teng CC; Chin KJ; Finger PT
    Br J Ophthalmol; 2009 Jun; 93(6):837-8. PubMed ID: 19471005
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model.
    Liarakos VS; Papaconstantinou D; Vergados I; Douvali M; Theodossiadis PG
    Eur J Ophthalmol; 2014; 24(3):299-308. PubMed ID: 24242219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil.
    Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P
    Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD.
    Lim JI; Niec M; Wong V
    Br J Ophthalmol; 2015 May; 99(5):618-23. PubMed ID: 25376617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot study.
    Flaxel C; Schain MB; Hamon SC; Francis PJ
    Retina; 2012 Mar; 32(3):417-23. PubMed ID: 21862953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgery and additional protontherapy for treatment of invasive and recurrent squamous cell carcinomas: technique and preliminary results].
    Caujolle JP; Maschi C; Chauvel P; Herault J; Gastaud P
    J Fr Ophtalmol; 2009 Dec; 32(10):707-14. PubMed ID: 19942315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.
    Nava-Castañeda A; Olvera-Morales O; Ramos-Castellon C; Garnica-Hayashi L; Garfias Y
    Clin Exp Ophthalmol; 2014 Apr; 42(3):235-41. PubMed ID: 23777441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
    Shields CL; Ramasubramanian A; Mellen PL; Shields JA
    Ophthalmology; 2011 Nov; 118(11):2133-2137.e1. PubMed ID: 21762990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
    Busbee BG; Ho AC; Brown DM; Heier JS; Suñer IJ; Li Z; Rubio RG; Lai P;
    Ophthalmology; 2013 May; 120(5):1046-56. PubMed ID: 23352196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of topical bevacizumab for conjunctival intraepithelial neoplasia.
    Özcan AA; Çiloğlu E; Esen E; Şimdivar GH
    Cornea; 2014 Nov; 33(11):1205-9. PubMed ID: 25014150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study.
    Chua BE; Nguyen DQ; Qin Q; Ruddle JB; Wells AP; Niyadurupola N; Gupta V; Wong TT; Coote MA; Crowston JG
    Clin Exp Ophthalmol; 2012 Nov; 40(8):773-9. PubMed ID: 22429268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.